BAP1 protein is a progression factor in malignant pleural mesothelioma (Q47734004)

5 February 2018

title

BAP1 protein is a progression factor in malignant pleural mesothelioma (English)

1 reference

5 February 2018

author name string

Lisa Arzt

1

1 reference

5 February 2018

Franz Quehenberger

2

1 reference

5 February 2018

Iris Halbwedl

3

1 reference

5 February 2018

Thomas Mairinger

4

1 reference

5 February 2018

Helmut H Popper

5

1 reference

5 February 2018

publication date

22 August 2013

1 reference

5 February 2018

Pathology Oncology Research

published in

1 reference

5 February 2018

volume

20

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

145-151

1 reference

5 February 2018

Malignant mesothelioma: biology, diagnosis and therapeutic approaches

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Malignant pleural mesothelioma: current treatments and emerging drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Multimodality approach in management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Pleural mesothelioma: little evidence, still time to do trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

21 January 2018

Malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Germline BAP1 mutations predispose to malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

BAP1, a candidate tumor suppressor protein that interacts with BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Germline mutations in BAP1 predispose to melanocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Genome-scale RNAi profiling of cell division in human tissue culture cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Cancer proliferation gene discovery through functional genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Functional inactivation of NF2/merlin in human mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

Defining the human deubiquitinating enzyme interaction landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9677-2

New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment

21 January 2018

1 reference

12 December 2020

Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres

1 reference

12 December 2020

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

1 reference

12 December 2020

Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.

1 reference

12 December 2020

Osteopontin is not a specific marker in malignant pleural mesothelioma

1 reference

12 December 2020

Toward an Improved Definition of the Tumor Spectrum Associated WithBAP1Germline Mutations

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S12253-013-9677-2

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018